EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)

Last updated:
2026-07-11
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A PHASE III RANDOMISED, DOUBLE-BLIND TRIAL TO EVALUATE EFFICACY AND SAFETY OF ONCE DAILY EMPAGLIFLOZIN 10 MG COMPARED TO PLACEBO, IN PATIENTS WITH CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)

Intervention/treatment:
EMPAGLIFLOZIN
Medical condition:
HEART FAILURE
Protocol code:
1245.110
Control number:
201575
Status:
Closed
Approved:
January 18, 2017
Date Completed:
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT03057951
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
18 Years and older
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Boehringer Ingelheim, Call Centre
Organization
Boehringer Ingelheim
Phone:
1-800-243-0127
Sponsor
BOEHRINGER INGELHEIM INTERNATIONAL GMBH

Locations

Alberta

Royal Alexandra Hospital
Edmonton, Alberta, T5H 3V9

British Columbia

Medical Arts Health Research Group
North Vancouver, British Columbia, V7M 2H4
Vancouver General Hospital
Vancouver, British Columbia, V5Z 1M9
Victoria Heart Institute Foundation
Victoria, British Columbia, V8R 1B2

Manitoba

St. Boniface General Hospital
Winnipeg, Manitoba, R2H 2A6

New Brunswick

G.A. Research Associates Ltd
Moncton, New Brunswick, E1G 1A7

Nova Scotia

QEII Health Sciences Centre
Halifax, Nova Scotia, B3H 3A7

Ontario

Brampton Cardio Pulmonary Clinic
Brampton, Ontario, L6W 2X7
Brampton Research Associates
Brampton, Ontario, L6Z 4N5
Cambridge Cardiac Care Inc.
Cambridge, Ontario, N1R 6V6
Canadian Phase Onward Inc.
Toronto, Ontario, M3J 0K2
Cardiovascular Contract Research Organization LTD
Greater Sudbury, Ontario, P3E 3Y9
Curnew Medicine Professional Corporation
Hamilton, Ontario, L8L 0A9
Dr. Louis C.H. Yao
York, Ontario, M9N 1W4
Dr. Saul Vizel
Cambridge, Ontario, N1R 7R1
Hamilton General Hospital
Hamilton, Ontario, L8L 2X2
Heart Health Institute
Scarborough Village, Ontario, M1B 4Z8
JBN Medical Diagnostic Services Inc.
Burlington, Ontario, L7M 4Y1
Kawartha Cardiology Clinical Trials
Peterborough, Ontario, K9J 0B2
M Heffernan Medicine Professional Corp.
Oakville, Ontario, L6K 3W7
Mohan Babapulle Medicine Professional Medicine
Waterloo, Ontario, N2T 0C1
North York Diagnostic and Cardiac Centre
Toronto, Ontario, M6B 1N6
PACE (Partners in Advanced Cardiac Evaluation)
Newmarket, Ontario, L3Y 2P6
Scarborough Cardiology Research
Scarborough Village, Ontario, M1E 5E9
University Hospital (LHSC)
London, Ontario, N6A 5A5

Quebec

Centre de Dépistage et Recherche Cardiovasculaire Rive-Sud
Longeuil, Quebec, J4M 2X1
Clinique Santé Cardio MC
Montreal, Quebec, H1T 3Y7
IUCPQ (Laval University)
Québec, Quebec, G1V 4G5
McGill University Health Centre (MUHC)
Montreal, Quebec, H4A 3J1
Montreal General Hospital - McGill University Health Centre
Montreal, Quebec, H3G 1A4
Montreal Heart Institute
Montreal, Quebec, H1T 1C8
ViaCar Recherche Clinique Inc
Brossard, Quebec, J4Z 2K9
ViaCar Recherche Clinique Inc
Greenfield Park, Quebec, J4V 2G8

Saskatchewan

Royal University Hospital
Saskatoon, Saskatchewan, S7N 0W8

Results

See the results from the trial NCT03057951. This is an external link. The information is not authorized by the Government of Canada.

Date posted:
Did you find what you were looking for?